Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2025-05-27
2027-08-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The CogAudio project aims to detect early and in an ambulatory mode in a memory centre a speech perception disorder in noise thanks to the VRB test in patients weakened by cognitive disorders.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Screening of Patients with Hearing Loss
NCT04672174
Cognitive Function and EEG Brain Network Remodeling Among Users of Hearing Aids With ARHL
NCT06893432
Hearing and Cognition in Aging Adults
NCT06183450
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
NCT05312983
Administration Method of Cognitive Screening in Older Individuals With Hearing Loss
NCT03402932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
perception disorder in noise in patients weakened by cognitive disorders.
The CogAudio project aims to detect early and in an ambulatory mode in a memory centre a speech perception disorder in noise thanks to the VRB test in patients weakened by cognitive disorders.
VRB test
V1 (inclusion) : VRB test for detecting speech comprehension disorders in noise.
V2 (3 months) : all patients ( independent of the result of the VRB test) will be invited to attend a hearing test within 3 months in order to confirm the diagnosis of deafness by means of a tone audiometry and an ENT medical consultation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VRB test
V1 (inclusion) : VRB test for detecting speech comprehension disorders in noise.
V2 (3 months) : all patients ( independent of the result of the VRB test) will be invited to attend a hearing test within 3 months in order to confirm the diagnosis of deafness by means of a tone audiometry and an ENT medical consultation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient mastering the French language
* Patient who has given written consent to participate in the trial
* Socially insured patient
* Patient willing to comply with all study procedures and duration
* Patient accompanied by a study partner
Exclusion Criteria
* History of progressive otological pathology or presence of tympanic obstruction (\>1/3 of the surface of the eardrum)
* History of unstabilized psychiatric pathology
* Major visual impairment (Age-Related Macular Degeneration AMD...)
* Established diagnosis of major language disorders (Primary Progressive Aphasia APP...)
* Major under legal protection measure
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Roger Salengro
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Pascaline Cassagnaud
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022_0392
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.